Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
ResMed Inc. RMD
$232.91
-$3.17 (-1.36%)
На 18:00, 12 мая 2023
+12.28%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
34486176888.00000000
-
week52high
247.65
-
week52low
189.40
-
Revenue
3578127000
-
P/E TTM
118
-
Beta
0.47750800
-
EPS
5.85000000
-
Last Dividend
1.76000000
-
Next Earnings Date
27 апр 2023 г. в 20:30
Описание компании
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| RBC Capital | Sector Perform | Outperform | 12 авг 2022 г. |
| JP Morgan | Neutral | Overweight | 12 авг 2022 г. |
| RBC Capital | Outperform | Outperform | 15 июн 2022 г. |
| RBC Capital | Outperform | Sector Perform | 06 июн 2022 г. |
| RBC Capital | Sector Perform | Sector Perform | 29 апр 2022 г. |
| RBC Capital | Outperform | Outperform | 13 сент 2022 г. |
| Citigroup | Buy | Neutral | 08 сент 2022 г. |
| B of A Securities | Buy | Neutral | 20 окт 2022 г. |
| Jefferies | Hold | 12 окт 2022 г. | |
| RBC Capital | Sector Perform | Sector Perform | 28 окт 2022 г. |
| Keybanc | Overweight | Overweight | 28 окт 2022 г. |
| JP Morgan | Overweight | Neutral | 17 янв 2023 г. |
| JP Morgan | Overweight | Overweight | 27 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Drexler Karen | D | 7987 | 594 | 02 февр 2023 г. |
| Farrell Michael J. | D | 60215 | 5675 | 17 янв 2023 г. |
| Farrell Michael J. | D | 436900 | 5675 | 17 янв 2023 г. |
| Farrell Michael J. | A | 442575 | 5675 | 17 янв 2023 г. |
| Douglas Robert Andrew | D | 226208 | 1500 | 17 янв 2023 г. |
| PENDARVIS DAVID | D | 97172 | 1500 | 03 янв 2023 г. |
| Farrell Michael J. | D | 65890 | 5675 | 15 дек 2022 г. |
| Farrell Michael J. | D | 436900 | 5675 | 15 дек 2022 г. |
| Farrell Michael J. | A | 442575 | 5675 | 15 дек 2022 г. |
| PENDARVIS DAVID | D | 98672 | 1500 | 05 дек 2022 г. |
Новостная лента
Sleep-Apnea Growth Stock Breaks Out On Record Earnings; Device Sales Surge
Investors Business Daily
01 мая 2023 г. в 15:15
Sleep-apnea device maker ResMed broke out after earnings, continuing its accelerating growth pace. The post Sleep-Apnea Growth Stock Breaks Out On Record Earnings; Device Sales Surge appeared first on Investor's Business Daily.
ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates
Zacks Investment Research
28 апр 2023 г. в 10:38
ResMed (RMD) reports a solid third-quarter top line, led by strong device sales growth through steady production and delivery of its cloud-connected flow generator devices to meet high market demand.
ResMed Inc. (RMD) Q3 2023 Earnings Call Transcript
Seeking Alpha
27 апр 2023 г. в 21:36
ResMed Inc. (RMD) Q3 2023 Earnings Call Transcript.
ResMed Gives Investors A Good Night's Sleep
Seeking Alpha
13 апр 2023 г. в 12:31
ResMed shares are selling on the expensive side of a fair value but the numbers and growth potential make us bullish on the stock. Fundamentals are strong and the forecast 6.3% annual market growth make this a stock valuable to retail value investors.
ResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023
GlobeNewsWire
06 апр 2023 г. в 16:05
SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2023 on Thursday, April 27, 2023, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.